Atlas Trials

A Data Collection Study for Patients With Adenocarcinoma Treated With the MyVaccx Immunotherapy Regimen.

Clinical trial NCT03695835 · COMPLETED

Trial details

NCT number
NCT03695835
Sponsor
Gary Onik MD
Status
COMPLETED
Study type
OBSERVATIONAL
Adenocarcinoma
Start date
2018-04-11
Primary completion
2019-07-08
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.